Management Options for Otitis Externa

Otitis externa is a common condition characterized by pain, itching, and discharge in the ear canal. Here are some management options for this condition:

Prescribe Topical Antibiotics: Topical antibiotics are the first-line treatment for otitis externa. Neomycin or clioquinol are recommended, and they may be combined with a topical corticosteroid if there is inflammation and eczema. Aminoglycosides should be used cautiously as second line if there is perforation of the eardrum.

Prescribe Oral Antibiotics: Oral antibiotics may be necessary if the patient is systemically unwell or there is preauricular lymphadenitis or cellulitis. Flucloxacillin or erythromycin is the drug of choice.

Refer to Ear, Nose and Throat (ENT) for Ear Wick Insertion: If there is extensive swelling of the auditory canal, an ear wick may be used. This is impregnated with antibiotic-steroid combination and is inserted into the auditory canal. However, if the tympanic membrane is visible, topical antibiotics would be the first-line treatment.

Prescribe Analgesia Only: Paracetamol or ibuprofen is usually sufficient for analgesia in cases of otitis externa. However, analgesia should be used in combination with antibiotics to aid in curing and preventing the worsening of symptoms.

Do Not Prescribe Topical Antifungals: Topical antifungals are not indicated in simple cases of otitis externa. They may be necessary if there is a secondary fungal infection, but this is not described in this case.

The 2010 NICE guidelines have been revised to recommend the use of both angiotensin-2 receptor blockers and hydralazine in combination with a nitrate as second-line treatments for heart failure, in addition to aldosterone antagonists. However, considering the patient’s recent myocardial infarction, the most appropriate option would be an aldosterone antagonist, as per the NICE guidelines. For further information, please refer to the guidelines.

Chronic heart failure can be managed through drug therapy, as outlined in the updated guidelines issued by NICE in 2018. While loop diuretics are useful in managing fluid overload, they do not reduce mortality in the long term. The first-line treatment for all patients is an ACE-inhibitor and a beta-blocker, with clinical judgement used to determine which one to start first. Aldosterone antagonists are the standard second-line treatment, but both ACE inhibitors and aldosterone antagonists can cause hyperkalaemia, so potassium levels should be monitored. SGLT-2 inhibitors are increasingly being used to manage heart failure with a reduced ejection fraction, as they reduce glucose reabsorption and increase urinary glucose excretion. Third-line treatment options include ivabradine, sacubitril-valsartan, hydralazine in combination with nitrate, digoxin, and cardiac resynchronisation therapy. Other treatments include annual influenza and one-off pneumococcal vaccines.

First Aid for Needlestick Injuries in Primary Care

Immediate first aid knowledge is crucial in managing needlestick injuries, especially in primary care where procedures like venepuncture and minor surgery are frequently performed. It is important to have a clear local policy on the management of needlestick injuries that is accessible to healthcare professionals.

In case of a needlestick injury, the first step is to encourage the wound to bleed and wash it with soap and water. It is important not to suck the wound or apply antiseptic agents as there is no evidence for their use or efficacy. The wound should also not be scrubbed with an abrasive. A simple waterproof plaster or dressing is appropriate to cover the wound. These measures may seem like common sense, but they should be part of any needlestick injury guidance or protocol.

Treatment and Prevention of Pertussis

Pertussis, commonly known as whooping cough, is a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. Treatment with antibiotics can reduce the infectivity of the disease, but it doesn’t shorten the duration of the illness. Macrolide antibiotics are the preferred treatment for pertussis.

Immunization is the most effective way to prevent pertussis. However, the vaccine provides only 95% protection and relies on a degree of herd immunity. Infants less than 6 months old and any unwell child should be admitted to the hospital for treatment.

If left untreated, pertussis can lead to complications such as bronchiectasis and pneumonia. Therefore, it is important to seek medical attention if you suspect you or your child has pertussis. Early diagnosis and treatment can help prevent the spread of the disease and reduce the risk of complications.

Pharmacological Management of Benign Prostatic Hyperplasia

Benign prostatic hyperplasia (BPH) is a common condition in older men that can cause urinary symptoms. Alpha-blockers, such as tamsulosin, are the first-line pharmacological treatment as they relax the smooth muscle of the bladder neck and improve urinary flow rates. Improvement in symptoms can be seen within a few days of therapy. Finasteride, an inhibitor of 5-alpha-reductase, can also be used to reduce prostatic volume over a period of around 6 months. However, it doesn’t provide rapid relief of symptoms. Cyproterone acetate and goserelin are not used in the treatment of BPH, as they are indicated for advanced prostate cancer. Oxybutynin, an antimuscarinic drug, can worsen symptoms of BPH and is not recommended for this condition.

For adults with mild facial cellulitis, the recommended treatment is a 7-day course of co-amoxiclav or clarithromycin for those with a penicillin allergy. A review should be arranged after 48 hours, either by telephone or face-to-face, depending on clinical judgement.

Urgent hospital admission is necessary for patients with red flags such as Eron Class III or IV cellulitis, severe or rapidly deteriorating cellulitis, immunocompromised individuals, very young or frail patients, those with significant lymphoedema, and those with facial or periorbital cellulitis unless it is very mild. For Eron Class II cellulitis, admission may not be necessary if the community has the facilities and expertise to administer intravenous antibiotics and monitor the patient, subject to local guidelines.

The Eron classification system can assist in determining the appropriate level of care and treatment. Class I patients show no signs of systemic toxicity and have no uncontrolled co-morbidities. Class II patients are either systemically unwell or have a comorbidity that may complicate or delay resolution of infection. Class III patients have significant systemic upset or limb-threatening infections due to vascular compromise. Class IV patients have sepsis syndrome or a severe life-threatening infection such as necrotising fasciitis.

Understanding Cellulitis: Symptoms, Diagnosis, and Treatment

Cellulitis is a common skin infection caused by Streptococcus pyogenes or Staphylococcus aureus. It is characterized by inflammation of the skin and subcutaneous tissues, usually on the shins, accompanied by erythema, pain, swelling, and sometimes fever. The diagnosis of cellulitis is based on clinical features, and no further investigations are required in primary care. However, bloods and blood cultures may be requested if the patient is admitted and septicaemia is suspected.

To guide the management of patients with cellulitis, NICE Clinical Knowledge Summaries recommend using the Eron classification. Patients with Eron Class III or Class IV cellulitis, severe or rapidly deteriorating cellulitis, very young or frail patients, immunocompromised patients, patients with significant lymphoedema, or facial or periorbital cellulitis (unless very mild) should be admitted for intravenous antibiotics. Patients with Eron Class II cellulitis may not require admission if the facilities and expertise are available in the community to give intravenous antibiotics and monitor the patient.

The first-line treatment for mild/moderate cellulitis is flucloxacillin, while clarithromycin, erythromycin (in pregnancy), or doxycycline is recommended for patients allergic to penicillin. Patients with severe cellulitis should be offered co-amoxiclav, cefuroxime, clindamycin, or ceftriaxone. Understanding the symptoms, diagnosis, and treatment of cellulitis is crucial for effective management and prevention of complications.

Understanding Pyrazinamide Side Effects during TB Treatment

Treatment for tuberculosis (TB) is typically initiated in specialist clinics, but patients may present in primary care if they experience adverse reactions, interactions, or side effects. As a healthcare provider, it is important to have an understanding of common side effects and potential problems during treatment. Pyrazinamide, a medication commonly used in TB treatment, can cause hyperuricaemia and attacks of gout. Additionally, patients may experience hepatitis and rashes as side effects of pyrazinamide. Being aware of these potential side effects can help healthcare providers monitor and manage patients’ treatment effectively.

The formula for NNT is the reciprocal of the absolute risk reduction or the difference between the control event rate and the experimental event rate. For example, if the control event rate is 0.04 and the experimental event rate is 0.03, the NNT would be 1 divided by 0.01.

Numbers needed to treat (NNT) is a measure that determines how many patients need to receive a particular intervention to reduce the expected number of outcomes by one. To calculate NNT, you divide 1 by the absolute risk reduction (ARR) and round up to the nearest whole number. ARR can be calculated by finding the absolute difference between the control event rate (CER) and the experimental event rate (EER). There are two ways to calculate ARR, depending on whether the outcome of the study is desirable or undesirable. If the outcome is undesirable, then ARR equals CER minus EER. If the outcome is desirable, then ARR is equal to EER minus CER. It is important to note that ARR may also be referred to as absolute benefit increase.

Treatment Options for Irritable Bowel Syndrome (IBS)

When it comes to treating irritable bowel syndrome (IBS), there are several options available. The National Institute for Health and Care Excellence (NICE) recommends tricyclic antidepressants as a second-line treatment if other medications have not been effective. Treatment should start at a low dose and be reviewed regularly. Acupuncture and aloe vera are not recommended by NICE for the treatment of IBS. It is suggested to limit intake of high-fibre foods and increase intake of fresh fruit, but to limit it to three portions per day. It’s important to consult with a healthcare professional to determine the best treatment plan for individual needs.

Guillain-Barre syndrome is suggested by the presence of progressive peripheral polyneuropathy with hyporeflexia. This syndrome typically presents as a symmetrical polyneuropathy that develops rapidly and is often preceded by an infection. It initially causes paraesthesia and lower limb weakness, which can quickly spread to involve the upper limb, cranial nerves, autonomic function, and respiratory function. As it is a disorder of the peripheral nervous system, it presents with lower motor neurone signs such as hyporeflexia.

Amyotrophic lateral sclerosis, on the other hand, is a disorder of the motor neurones and doesn’t typically cause sensory disturbance such as paraesthesia. It often has a slower onset.

Multiple sclerosis affects the central nervous system and therefore presents with upper motor neurone signs such as hyperreflexia.

Myasthenia gravis is a neuromuscular junction disorder that is characterized by fatiguability and doesn’t typically cause sensory disturbance.

Although the features of transverse myelitis and Guillain-Barre can overlap and coexist, the absence of a sensory level on examination makes transverse myelitis less likely in this case.

Guillain-Barre Syndrome: A Breakdown of its Features

Guillain-Barre syndrome is a condition that occurs when the immune system attacks the peripheral nervous system, resulting in demyelination. This is often triggered by an infection, with Campylobacter jejuni being a common culprit. In the initial stages of the illness, around 65% of patients experience back or leg pain. However, the characteristic feature of Guillain-Barre syndrome is progressive, symmetrical weakness of all limbs, with the legs being affected first in an ascending pattern. Reflexes are reduced or absent, and sensory symptoms tend to be mild. Other features may include a history of gastroenteritis, respiratory muscle weakness, cranial nerve involvement, diplopia, bilateral facial nerve palsy, oropharyngeal weakness, and autonomic involvement, which can lead to urinary retention and diarrhea. Less common findings may include papilloedema, which is thought to be secondary to reduced CSF resorption. To diagnose Guillain-Barre syndrome, a lumbar puncture may be performed, which can reveal a rise in protein with a normal white blood cell count (albuminocytologic dissociation) in 66% of cases. Nerve conduction studies may also be conducted, which can show decreased motor nerve conduction velocity due to demyelination, prolonged distal motor latency, and increased F wave latency.

Lichen planus is a skin condition characterized by a rash of purple, itchy, polygonal papules on the flexor surfaces of the body. The affected area may also have Wickham’s striae. Oral involvement is common. In elderly women, lichen sclerosus may present as itchy white spots on the vulva.

Lichen planus is a skin condition that has an unknown cause, but is believed to be related to the immune system. It is characterized by an itchy rash that appears as small bumps on the palms, soles, genital area, and inner surfaces of the arms. The rash often has a polygonal shape and a distinctive pattern of white lines on the surface, known as Wickham’s striae. In some cases, new skin lesions may appear at the site of trauma, a phenomenon known as the Koebner phenomenon. Oral involvement is common, with around 50% of patients experiencing a white-lace pattern on the buccal mucosa. Nail changes, such as thinning of the nail plate and longitudinal ridging, may also occur.

Lichenoid drug eruptions can be caused by certain medications, including gold, quinine, and thiazides. Treatment for lichen planus typically involves the use of potent topical steroids. For oral lichen planus, benzydamine mouthwash or spray is recommended. In more severe cases, oral steroids or immunosuppressive medications may be necessary. Overall, lichen planus can be a challenging condition to manage, but with proper treatment, symptoms can be controlled and quality of life can be improved.

The Relationship Between Childhood Separation Anxiety and Mental Disorders

Separation anxiety disorder is a condition characterized by excessive anxiety related to separation from an attachment figure, such as a mother. Studies have shown that this disorder is a strong risk factor for developing mental disorders, particularly panic disorder and depression, in people aged 19-30 years. However, there is no proven link between childhood separation anxiety and irritable bowel syndrome, obsessive-compulsive disorder, schizophrenia, or somatic symptom disorder. While negative childhood experiences may play a role in the development of some mental disorders, separation anxiety in childhood is not directly related to these conditions.

Understanding Different Types of Thought Experiences

There are various types of thought experiences that individuals may encounter. One of these is thought broadcast, where others can seemingly hear or read one’s thoughts as they are being broadcasted from the individual. On the other hand, thought insertion and withdrawal refer to the experience of having thoughts inserted into or taken out of one’s mind by an external force. In thought blocking, individuals may suddenly find themselves unable to continue speaking as their minds go blank. Meanwhile, thought echo involves hearing one’s own thoughts being spoken aloud after thinking them. Finally, auditory hallucinations refer to the perception of hearing sounds or voices without any external stimulus. Understanding these different types of thought experiences can help individuals better recognize and cope with them.

Common Causes of Visual Impairment: A Comparison of Vitreous Haemorrhage, Central Retinal Artery Occlusion, Branch Retinal Vein Occlusion, Commotio Retinae, and Vitreous Detachment

Vitreous Haemorrhage: Patients with vitreous haemorrhage often experience floaters and a red hue, and the blood appears as a cloud in the vitreous. This condition is commonly seen in patients with proliferative diabetic retinopathy, as well as those who have experienced trauma or have other causes of proliferative retinopathy. It may also be an early sign of retinal tears and detachment.

Central Retinal Artery Occlusion: Sudden loss of vision is the hallmark of central retinal artery occlusion. Fundoscopy reveals a pale retina due to retinal ischaemia, with the centre of the macula appearing as a cherry-red spot.

Branch Retinal Vein Occlusion: Fundoscopy reveals superficial haemorrhages, retinal oedema, and cotton-wool spots in a sector of retina drained by the affected vein. The obstructed vein is dilated and tortuous. Visual loss largely depends on the compromise to macular drainage, and peripheral occlusions may be asymptomatic.

Commotio Retinae: Commotio retinae, or Berlin’s oedema, is caused by blunt injury to the eye. Decreased vision in the injured eye occurs a few hours after the injury. The retina appears opaque and white in colour in the periphery, but the blood vessels are normal. It is usually self-limiting.

Vitreous Detachment: Vitreous detachment is the most common cause of light flashes and floaters, but not visual loss. A slit-lamp examination is mandatory to exclude retinal tears, which are present in about 10% of cases.

Adding an inhaled long-acting beta-2 agonist (LABA) would not be the appropriate course of action at this time. It should only be considered as an add-on therapy if the patient’s asthma remains uncontrolled despite regular use of inhaled corticosteroids.

Similarly, adding a leukotriene receptor antagonist (LTRA) would not be recommended at this stage. It should only be considered if the patient’s asthma remains uncontrolled despite using a combination of LABA and ICS, or if low-dose ICS is insufficient.

Doubling the dose of beclomethasone dipropionate would also not be the correct approach. This would result in a medium dose of ICS, which is only recommended if the patient remains symptomatic despite a combination of low-dose ICS and LABA. Alternatively, an LTRA may be added.

Stopping beclomethasone dipropionate and relying solely on salbutamol as needed would not be advisable. Any reduction in ICS should be done gradually to minimize the risk of worsening symptoms.

Stepping Down Asthma Treatment: BTS Guidelines

The British Thoracic Society (BTS) recommends that asthma treatment should be reviewed every three months to consider stepping down treatment. However, the guidelines do not suggest a strict move from one step to another but rather advise taking into account the duration of treatment, side-effects, and patient preference. When reducing the dose of inhaled steroids, the BTS suggests doing so by 25-50% at a time.

Patients with stable asthma may only require a formal review once a year. However, if a patient has recently had an escalation of asthma treatment, they are likely to be reviewed more frequently. It is important to follow the BTS guidelines to ensure that patients receive the appropriate level of treatment for their asthma and to avoid unnecessary side-effects.

Heritability Scores of Different Disorders

Mumps, a contagious viral infection, has the lowest heritability score among the disorders mentioned. This means that the risk of developing mumps is primarily due to exposure to the infective agent rather than genetic factors. On the other hand, the other disorders listed have a genetic component in their development. For instance, cystic fibrosis is caused by a mutation in a specific gene and is inherited in an autosomal recessive manner. Understanding the heritability scores of different disorders can help in identifying the underlying causes and developing appropriate treatment strategies.

Understanding Isotretinoin: Important Information to Know

Isotretinoin is a medication used to treat severe inflammatory acne. However, there are important considerations to keep in mind before starting treatment. Here are some key points to be aware of:

Pregnancy should be avoided: Isotretinoin is known to be teratogenic, meaning it can cause birth defects. Women of childbearing age should use at least one form of contraception during treatment and for one month after treatment.

Serum lipids may decrease: While taking isotretinoin, minor changes in serum lipids and liver function may occur. These are monitored during treatment and the medication may be stopped if the tests worsen.

Emollients should not be used: Isotretinoin can cause dryness of the skin and mucous membranes, especially the lips. While patients may need to apply emollients, they should be cautious as they can interfere with the medication’s effectiveness.

Depression is a rare side effect: While depression is listed as a rare side effect of isotretinoin, there is no clear link between the medication and depression. Patients should be asked about mood and any changes should be reported to their healthcare provider.

The skin becomes greasier: Isotretinoin reduces sebum secretion, which can cause dryness of the skin and mucous membranes. However, some patients may experience an initial increase in oil production before seeing improvement in their acne.

Treatment Options for Ankylosing Spondylitis

Ankylosing spondylitis is a type of inflammatory arthritis that primarily affects the spine and sacroiliac joints. The following are some of the treatment options available for managing this condition:

Oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
NSAIDs are the first-line medication recommended by the National Institute for Health and Care Excellence (NICE) for managing ankylosing spondylitis. They help to reduce pain and stiffness in the affected joints.

Corticosteroid Injection
Intra-articular steroid injections can be used to treat a flare of ankylosing spondylitis that has not responded to oral NSAIDs or other oral treatments. However, repeated injections are associated with risks such as joint infection.

Oral Corticosteroids
Oral corticosteroids can be used to treat symptoms that are not responding to other oral treatments. However, their use is limited due to the multiple complications and side effects associated with long-term use.

Paracetamol and Codeine
If patients have an allergy, severe asthma, or a high risk for gastrointestinal bleeding, alternative analgesia should be considered, such as paracetamol and codeine.

Tumour Necrosis Factor (TNF)-Alpha Inhibitor
TNF-alpha inhibitors are used to treat ankylosing spondylitis in patients whose symptoms are not controlled on other treatments. However, they must be prescribed and monitored in secondary care.

Managing Ankylosing Spondylitis: Treatment Options

Men and women who are undergoing methotrexate treatment must use reliable contraception throughout the duration of the treatment and for a minimum of 6 months after it has ended.

Methotrexate is an antimetabolite that hinders the activity of dihydrofolate reductase, an enzyme that is crucial for the synthesis of purines and pyrimidines. It is a significant drug that can effectively control diseases, but its side-effects can be life-threatening. Therefore, careful prescribing and close monitoring are essential. Methotrexate is commonly used to treat inflammatory arthritis, especially rheumatoid arthritis, psoriasis, and acute lymphoblastic leukaemia. However, it can cause adverse effects such as mucositis, myelosuppression, pneumonitis, pulmonary fibrosis, and liver fibrosis.

Women should avoid pregnancy for at least six months after stopping methotrexate treatment, and men using methotrexate should use effective contraception for at least six months after treatment. Prescribing methotrexate requires familiarity with guidelines relating to its use. It is taken weekly, and FBC, U&E, and LFTs need to be regularly monitored. Folic acid 5mg once weekly should be co-prescribed, taken more than 24 hours after methotrexate dose. The starting dose of methotrexate is 7.5 mg weekly, and only one strength of methotrexate tablet should be prescribed.

It is important to avoid prescribing trimethoprim or co-trimoxazole concurrently as it increases the risk of marrow aplasia. High-dose aspirin also increases the risk of methotrexate toxicity due to reduced excretion. In case of methotrexate toxicity, the treatment of choice is folinic acid. Overall, methotrexate is a potent drug that requires careful prescribing and monitoring to ensure its effectiveness and safety.

It is crucial to refer any patient who presents with new synovitis to a rheumatologist urgently for evaluation. This is because the patient may have an inflammatory joint disease that requires immediate attention. The rheumatologist can conduct blood tests to check for related auto-immune antibodies, including Antinuclear antibody and rheumatoid factor, while the patient is being referred.

In case the patient is febrile or has risk factors for septic arthritis, such as intravenous drug use, it would be useful to organise joint aspiration. However, it is best to leave this decision to the rheumatologist.

It is not advisable to reassure the patient and avoid referring them to a specialist. Early identification and treatment of inflammatory arthropathy can prevent long-term functional impairment.

Referring the patient to rheumatology is necessary and should be done urgently. Delaying the referral can lead to the loss of hand function and other debilitating effects of untreated inflammatory arthritis.

Referring the patient to the emergency department is not required unless the patient is febrile and hypotensive.

Rheumatoid arthritis can be diagnosed clinically, which is considered more important than using specific criteria. However, the American College of Rheumatology has established classification criteria for rheumatoid arthritis. These criteria require the presence of at least one joint with definite clinical synovitis that cannot be explained by another disease. A score of 6 out of 10 is needed for a definite diagnosis of rheumatoid arthritis. The score is based on factors such as the number and type of joints involved, serology (presence of rheumatoid factor or anti-cyclic citrullinated peptide antibody), acute-phase reactants (such as CRP and ESR), and duration of symptoms. These criteria are used to classify patients with rheumatoid arthritis for research and clinical purposes.

Handwashing with soap and warm water before and after contact with those infected with norovirus is the most effective way to prevent its spread, while alcohol gels are less effective. Antivirals have no role in treating norovirus, which is not a blood-borne virus and is commonly spread through contaminated food or drinks, touching contaminated surfaces or objects, or direct contact with an infected person. Staff who have had norovirus must stay away from work for at least 48 hours after their symptoms have stopped.

Norovirus, also known as the winter vomiting bug, is a common cause of gastroenteritis in the UK. It is a type of RNA virus that can cause symptoms such as nausea, vomiting, and diarrhea, as well as headaches, low-grade fevers, and myalgia. The virus is highly contagious and can be transmitted through the fecal-oral route, as well as through aerosolized particles from vomit or contaminated bodily fluids. Good hand hygiene and isolation of infected individuals are important in limiting transmission. Diagnosis is typically made through clinical history and stool culture viral PCR. While the infection is self-limiting in most cases, dehydration and electrolyte imbalances can occur and require supportive management. Other differential diagnoses include rotavirus, E. coli, and Salmonella infections, each with their own distinguishing features.

Improving Medication Adherence: The Importance of Patient Involvement in Treatment Decisions

Adherence to medication is a common issue across various chronic diseases, including coronary heart disease, mental health, diabetes, and cancer. Despite the severity of some illnesses, patients often struggle to adhere to their medication regimen. However, actively involving patients in their treatment decisions can improve their adherence. The National Institute for Health and Care Excellence recommends a non-judgemental discussion that explores the patient’s perceptions and preferences about medication.

Even after a life-threatening event, adherence to medication remains poor. For instance, only half of the patients hospitalised for acute myocardial infarction were still taking their medication two years after starting therapy. Poor health literacy may also contribute to a lack of understanding of treatment instructions, leading to non-adherence. Additionally, the elderly face challenges such as multiple medications with frequent dosing and potentially decreased dexterity and cognitive functioning. Communication between hospitals and General Practitioners could also be poor, leading to medication lists that are not up to date and conflicting messages for patients.

In conclusion, involving patients in their treatment decisions can improve medication adherence, which is crucial for managing chronic diseases. Healthcare providers should strive to communicate effectively with patients, especially those with low health literacy and the elderly, to ensure they understand their treatment instructions and can manage their medications effectively.

Malignant Melanoma: Types, Incidence, and Demographics

Malignant melanoma is a type of skin cancer that can occur not only on the skin but also on mucosal surfaces such as the subungual, buccal, and anal areas. While most cases of melanoma occur on the trunk or legs, it can also present in other areas. The incidence of malignant melanoma has been rapidly increasing in white populations worldwide, with a threefold increase in Great Britain from 1971 to 1996.

Amelanotic malignant melanoma is a type of melanoma that lacks pigment and is often associated with metastasis to the skin. It is believed that more than 50% of cases arise without a pre-existing pigmented lesion. Tumour size is only one of the criteria used in the 2009 AJCC Melanoma Staging and Classification.

According to Cancer Research UK, the demographics of malignant melanoma in the UK show that it is more common in females than males and is most frequently diagnosed in people aged 65-69. It is also more common in affluent areas and in those with fair skin, light hair, and blue or green eyes. Regular skin checks and sun protection are important in preventing and detecting malignant melanoma.

Managing Nausea and Vomiting in Palliative Care: Medications to Consider

Nausea and vomiting are common symptoms in palliative care, and can be caused by a variety of factors such as drug toxicity or metabolic disturbances. To manage these symptoms, several medications can be considered.

Haloperidol is often the first-line drug for opioid-induced nausea, renal failure, and hypercalcaemia. Metoclopramide and levomepromazine are alternative options. For nausea caused by cytotoxic therapy or radiotherapy, ondansetron can be used.

Ranitidine may be beneficial if gastric or oesophageal stasis is an issue. Cyclizine is useful for managing vagally-mediated nausea and vomiting caused by mechanical bowel obstruction, vestibular disturbance, and Intracranial disease. Dexamethasone can be added to cyclizine in scenarios where Intracranial pressure is raised.

Finally, hyoscine butylbromide can be used for managing bowel colic and excessive gastrointestinal secretions. When selecting medications, it is important to consider the underlying cause of the nausea and vomiting, as well as the patient’s individual needs and preferences.

Erythrodermic Psoriasis: A Dermatological Emergency

Erythrodermic psoriasis is a severe form of psoriasis that requires immediate medical attention. It is characterized by widespread whole body erythema and systemic unwellness, which can lead to complications such as hypothermia and heart failure. This condition can also be caused by other dermatological conditions or medications such as lithium or anti-malarials.

Injudicious use of steroids with rapid withdrawal can also trigger erythroderma. Therefore, it is crucial to seek medical attention as soon as possible to prevent skin failure. The correct course of action is immediate hospital admission for supervised treatment. Dermatologists recommend close monitoring and management of erythrodermic psoriasis to avoid life-threatening complications.

Deltoid Muscle and Nerve Supply

The deltoid muscle, located in the shoulder, is innervated by the circumflex humeral (axillary) nerve. While it is not a common occurrence, injury to this nerve can result in complications with the deltoid muscle. In fact, it is the most likely complication of this type of injury. It is important to be aware of this potential complication in order to properly diagnose and treat any issues that may arise.

Liver Disorders in Pregnancy: Differential Diagnosis

During pregnancy, various liver disorders can occur, leading to abnormal liver function tests. Intrahepatic cholestasis of pregnancy is the most common pregnancy-related liver disorder, affecting 0.1-1.5% of pregnancies. It typically presents in the late second or early third trimester with generalized itching, starting on the palms and soles. An elevated alanine aminotransferase (ALT) is a more sensitive marker than aspartate aminotransferase (AST), and a fasting serum bile acid concentration of greater than 10 mmol/l is the key diagnostic test. Primary biliary cholangitis and acute fatty liver of pregnancy are less likely diagnoses, while cholelithiasis and hyperemesis gravidarum have different clinical presentations. Early diagnosis and management of liver disorders in pregnancy are crucial to prevent adverse outcomes such as prematurity and stillbirth.

Ectopic Pregnancy and Contraception

According to the FSRH, a previous ectopic pregnancy is not an absolute contraindication to the use of intrauterine methods of contraception. In fact, the overall risk of ectopic pregnancy is reduced with the use of IUC when compared to using no contraception. However, if pregnancy does occur with an intrauterine method in situ, the risk of an ectopic pregnancy occurring is increased. In some studies, half of the pregnancies that occurred were ectopic.

It is important to note that older editions of an Australian primary care textbook list an ectopic pregnancy as a contraindication. However, the latest FSRH advice is the reference on which the RCGP is likely to base their answers. Therefore, healthcare professionals should follow the most up-to-date guidelines when considering contraception options for patients with a history of ectopic pregnancy.

Aspirin Overdose: Symptoms and Management

Aspirin overdose can be potentially fatal, as its effects are dose-related. Unlike with paracetamol, there are many early clinical features of aspirin overdose. These include nausea and vomiting, sweating, hyperventilation, vertigo, and tinnitus. More severe manifestations of overdose include lethargy, coma, seizures, hypotension, heart block, and pulmonary edema.

Immediate referral to the hospital and close monitoring with supportive measures are necessary for managing aspirin overdose. In severe cases, dialysis may be indicated.

Antiphospholipid Syndrome: A Cause of Recurrent Miscarriage

Antiphospholipid syndrome is a medical condition that can lead to recurrent miscarriage. It can also present as arterial or venous thrombosis, livedo reticularis rash, stroke, adrenal hemorrhage, migraine, myelitis, myocardial infarction, or multi-infarct dementia. Anticardiolipin antibodies may be found in patients with this syndrome. Venous thrombi occur more often if lupus anticoagulant is positive, while arterial thrombi occur if IgG or IgM antiphospholipid antibody are positive. Long-term warfarin is indicated for treatment.

Initially, it was believed that up to 30% of SLE sufferers had antiphospholipid syndrome. However, it is now thought that primary antiphospholipid syndrome is a separate entity consisting of a tendency to thrombosis, positive antiphospholipid antibodies, but the absence of clinical features of SLE. It is important to recognize and diagnose this syndrome early to prevent complications such as recurrent miscarriage and thrombosis.